Cite as: Cold Spring Harb. Protoc.; 2006; doi:10.1101/pdb.prot4536

This Protocol
Right arrow Full Text
Right arrow Update/discuss this protocolDiscussion icon
Right arrow Alert me when this protocol is cited
Right arrow Alert me when comments are published
Right arrow Alert me if a correction is posted
Services
Right arrow Similar protocols in this database
Right arrow Alert me to new releases of protocols
Right arrow Save to Personal Folders
Right arrow Download to citation manager
Right arrow Printer-friendly versionPrinter-friendly version
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harlow, E.
Right arrow Articles by Lane, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Harlow, E.
Right arrow Articles by Lane, D.
Related Collections
Right arrow Antibodies, general
Right arrow Monoclonal Antibodies
Right arrow Proteins and Proteomics, general
Right arrow Preparation of Cellular and Subcellular Extracts
Right arrow Immunoprecipitation
Right arrowRelated Protocol
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Legend icon

protocolProtocol

Immunoprecipitation: Purifying the Immune Complexes

Ed Harlow and David Lane

This protocol was adapted from "Immunoprecipitation," Chapter 7, in Using Antibodies by Ed Harlow and David Lane. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 1999.


INTRODUCTION

In this protocol, immune complexes are formed by the addition of antibodies to cell lysates. The antibodies bind to their cognate antigen from a lysate. Protein A or protein G beads are then added to the solution containing antibody-antigen complexes, and the proteins that do not bind to the beads are removed by washing. The correct controls for immunoprecipitation should include nonimmune antibodies that are as close as possible to the specific antibody; for example, polyclonal serum should be compared to polyclonal serum from the same species (ideally a prebleed from the same animal used for immunization). For monoclonal antibodies, the control must be from the same source as the specific antibody. Do not use tissue culture supernatants from parental myeloma cells as they do not contain antibodies. Suitable control hybridoma cell lines can be obtained from the American Type Culture Collection and the European Collection of animal cell cultures.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Protocol

Immunoprecipitation: Preclearing the Lysate
Ed Harlow and David Lane
CSH Protocols 2006: 4535. [Abstract] [Full Text]